These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9178769)

  • 1. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites.
    Hime GR; Dhungat MP; Ng A; Bowtell DD
    Oncogene; 1997 Jun; 14(22):2709-19. PubMed ID: 9178769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
    Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
    Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cbl-3: a new mammalian cbl family protein.
    Keane MM; Ettenberg SA; Nau MM; Banerjee P; Cuello M; Penninger J; Lipkowitz S
    Oncogene; 1999 Jun; 18(22):3365-75. PubMed ID: 10362357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
    Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
    Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cbl family of signal transduction molecules.
    Smit L; Borst J
    Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
    Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
    Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
    Liang Y; Kurakin A; Roizman B
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Drosophila analogue of v-Cbl is a dominant-negative oncoprotein in vivo.
    Robertson H; Hime GR; Lada H; Bowtell DD
    Oncogene; 2000 Jul; 19(29):3299-308. PubMed ID: 10918586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor.
    Meisner H; Czech MP
    J Biol Chem; 1995 Oct; 270(43):25332-5. PubMed ID: 7592693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The c-Cbl oncoprotein.
    Lupher ML; Andoniou CE; Bonita D; Miyake S; Band H
    Int J Biochem Cell Biol; 1998 Apr; 30(4):439-44. PubMed ID: 9675877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.
    Yoon CH; Lee J; Jongeward GD; Sternberg PW
    Science; 1995 Aug; 269(5227):1102-5. PubMed ID: 7652556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
    Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
    J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
    Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
    Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.